Wegovy Long Term Side Effects UK - Safety Guide £69.00

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy Long Term Side Effects UK Price - £69.00

Get Wegovy at the cheapest UK price from £69.00 with £20 off first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding Wegovy Long Term Side Effects: Clinical Evidence and Safety Profile

Wegovy long term side effects are a critical consideration for patients committing to extended semaglutide treatment for weight management. While clinical trials demonstrate sustained efficacy over 68 weeks, understanding the safety profile beyond initial months helps patients and prescribers make informed decisions. Our UK clinical team provides comprehensive guidance on monitoring, managing, and mitigating potential long-term effects throughout your treatment journey.

What Are the Most Common Wegovy Long Term Side Effects?

The STEP clinical trial programme, which followed participants for up to 68 weeks, identified several wegovy long term side effects that persist beyond the initial titration phase [1]. Gastrointestinal symptoms remain the most frequently reported, though their intensity typically decreases after the first 3-6 months. Approximately 44% of participants experienced nausea during the study period, with most cases classified as mild to moderate severity.

Beyond digestive effects, long-term Wegovy use has been associated with gallbladder-related complications in 1.6% of clinical trial participants compared to 0.7% in placebo groups [1]. This includes cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation), particularly in patients experiencing rapid weight loss exceeding 1.5kg per week. Regular monitoring by your prescriber helps identify early warning signs such as upper right abdominal pain or yellowing of the skin.

Cardiovascular benefits observed in the SELECT trial demonstrate that wegovy long term side effects must be weighed against significant health improvements [2]. Participants showed a 20% reduction in major adverse cardiovascular events over a median follow-up of 40 months, suggesting the long-term safety profile supports extended use in appropriate patient populations when properly supervised.

How Do Wegovy Long Term Side Effects Differ From Short-Term Reactions?

Initial wegovy long term side effects often mirror acute reactions but with distinct temporal patterns. Nausea, vomiting, and diarrhoea typically peak during dose escalation phases and diminish significantly by week 20 in most patients [3]. However, approximately 15% of long-term users report persistent mild gastrointestinal symptoms that require ongoing dietary modifications and hydration strategies.

Emerging long-term considerations include potential impacts on bone mineral density and lean muscle mass preservation. Studies indicate that weight loss achieved through GLP-1 receptor agonists comprises approximately 25-30% lean tissue, compared to 20-25% with lifestyle modification alone [3]. This necessitates protein optimisation (1.2-1.6g per kg ideal body weight) and resistance training throughout treatment to mitigate muscle loss.

Metabolic Adaptations During Extended Wegovy Treatment

Long-term semaglutide use induces metabolic adaptations beyond initial weight reduction. Resting metabolic rate decreases proportionally to weight loss, averaging 10-15% reduction in patients losing 15% or more of body weight [4]. Understanding these wegovy long term side effects helps set realistic expectations for weight maintenance phases and informs nutritional planning with your healthcare team.

Are There Serious Wegovy Long Term Side Effects Requiring Medical Attention?

While most wegovy long term side effects are manageable, several serious conditions warrant immediate medical assessment. Acute pancreatitis, though rare (occurring in 0.2% of trial participants), represents a potentially life-threatening complication [1]. Symptoms include severe persistent abdominal pain radiating to the back, nausea, and vomiting. Any patient experiencing these symptoms should discontinue Wegovy and seek urgent medical evaluation.

Thyroid C-cell tumours emerged as a theoretical concern in rodent studies, prompting a boxed warning on semaglutide products [5]. However, post-marketing surveillance and long-term human data have not established a causal relationship. Patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use Wegovy. Regular monitoring of thyroid function is not routinely required but may be considered in high-risk populations.

Diabetic retinopathy complications have been observed in patients with pre-existing diabetes transitioning to semaglutide, particularly when rapid glycaemic improvement occurs [5]. Though Wegovy is licensed for weight management rather than diabetes treatment, patients with concurrent diabetes should undergo baseline ophthalmological assessment and regular monitoring throughout extended treatment.

Recognising Warning Signs of Wegovy Long Term Side Effects

Effective long-term management requires patient education on distinguishing expected effects from concerning symptoms. Persistent vomiting preventing adequate hydration, severe abdominal pain, significant mood changes, or suicidal ideation all necessitate immediate prescriber contact. Our clinical team at Cured Pharmacy provides ongoing monitoring support, with superintendent pharmacist Tarun Kumar (GPhC 2233073) available to address safety concerns throughout your treatment journey.

Treatment Primary Mechanism Most Common Long-Term Effects Starting Price
Wegovy (Semaglutide) GLP-1 receptor agonist GI symptoms, gallbladder events from £89.00
Mounjaro (Tirzepatide) Dual GLP-1/GIP agonist GI symptoms, injection site reactions from £145.00
Saxenda (Liraglutide) GLP-1 receptor agonist Nausea, injection site reactions from £68.00
Orlistat Lipase inhibitor GI effects, fat-soluble vitamin depletion from £32.00
Mysimba Bupropion/Naltrexone combination Nausea, headache, blood pressure changes from £125.95

How Can Wegovy Long Term Side Effects Be Minimised?

Strategic dose titration remains the most effective method for reducing wegovy long term side effects. The standard escalation schedule increases the dose every four weeks, allowing physiological adaptation to GLP-1 receptor stimulation [1]. Some patients benefit from extended titration intervals, particularly those experiencing persistent gastrointestinal symptoms. Your prescriber can modify the schedule whilst maintaining therapeutic efficacy.

Dietary modifications significantly impact tolerability during long-term Wegovy use. Smaller, more frequent meals (5-6 per day) reduce gastric distension and minimise nausea. Avoiding high-fat foods, particularly during the first 48 hours post-injection, decreases delayed gastric emptying effects. Adequate hydration (2-2.5 litres daily) prevents constipation, one of the more persistent wegovy long term side effects reported beyond six months.

Injection technique optimisation often overlooked but influences local side effects and medication absorption. Rotating injection sites between abdomen, thigh, and upper arm prevents lipohypertrophy and ensures consistent bioavailability. Allowing the pen to reach room temperature before injection and injecting slowly over 5-10 seconds reduces injection site reactions that can persist with long-term use.

What Does Long-Term Safety Data Reveal About Wegovy Long Term Side Effects?

The STEP 5 extension study, which followed participants for 104 weeks, provides the most comprehensive data on wegovy long term side effects in weight management populations [6]. Discontinuation rates due to adverse events were 6.7% in the semaglutide group versus 3.2% in placebo, with gastrointestinal disorders accounting for the majority of withdrawals. Importantly, no new safety signals emerged in the second year of treatment compared to the first.

Cardiovascular outcome data from the SELECT trial, spanning up to 5 years of follow-up, demonstrated no increased risk of major adverse cardiovascular events with long-term semaglutide use [2]. In fact, participants showed sustained cardiovascular benefits, with hazard ratios favouring semaglutide across multiple endpoints including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke.

Real-world evidence from post-marketing surveillance across the UK and Europe continues to monitor wegovy long term side effects beyond controlled trial settings. The MHRA Yellow Card scheme enables healthcare professionals and patients to report suspected adverse reactions, contributing to ongoing safety assessment. As of 2024, the benefit-risk profile remains favourable for appropriate patient populations under medical supervision.

Comparing Wegovy Long Term Side Effects to Other Weight Management Medications

When evaluating wegovy long term side effects against alternative treatments, semaglutide demonstrates a distinct safety profile. Orlistat primarily causes gastrointestinal effects related to fat malabsorption, whilst Mysimba carries neuropsychiatric considerations. Wegovy's GLP-1 mechanism offers metabolic benefits extending beyond weight loss, including improvements in inflammatory markers and liver fat content observed in long-term studies [6]. Available from £69.00 at Cured Pharmacy, Wegovy represents a clinically supported option for patients requiring sustained pharmacological weight management support.

Managing Wegovy Long Term Side Effects: Practical Patient Guidance

Successful long-term Wegovy treatment requires proactive management strategies for anticipated wegovy long term side effects. Establishing a symptom diary during the first 12 weeks helps identify patterns and triggers, enabling targeted interventions. Recording injection timing, meal composition, symptom severity, and daily weight provides valuable data for prescriber consultations and treatment optimisation.

Nutritional supplementation becomes increasingly important during extended treatment. Multivitamin supplementation ensures adequate micronutrient intake, particularly for patients experiencing reduced food variety due to appetite suppression. Calcium and vitamin D supplementation (800-1000 IU daily) supports bone health in patients losing significant weight. Protein supplementation may benefit those struggling to meet elevated protein requirements through whole foods alone.

Regular clinical monitoring forms the cornerstone of safe long-term Wegovy use. Baseline assessments should include liver function tests, renal function, lipid profile, and HbA1c (if diabetic). Follow-up monitoring at 3-6 month intervals allows early detection of metabolic changes and ensures wegovy long term side effects are identified before becoming clinically significant. Our UK-registered clinical team provides ongoing assessment support, with transparent pricing from £69.00 and no hidden consultation fees.

Scientific References

  1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., ... & Ryan, D. H. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine, 389(24), 2221-2232. [accessed 15 August 2026]
  3. Rubino, D. M., Greenway, F. L., Khalid, U., O'Neil, P. M., Rosenstock, J., Sørrig, R., ... & Investigators, S. (2021). Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes. JAMA, 327(2), 138-150. [accessed 15 August 2026]
  4. Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011). Long-term persistence of hormonal adaptations to weight loss. New England Journal of Medicine, 365(17), 1597-1604. [accessed 15 August 2026]
  5. Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., ... & Investigators, S. (2016). Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 375(19), 1834-1844. [accessed 15 August 2026]
  6. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & STEP 5 Study Group. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
  7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Do wegovy long term side effects worsen over time?
Most wegovy long term side effects, particularly gastrointestinal symptoms, actually improve after the first 3-6 months as your body adapts to semaglutide. Clinical trial data shows discontinuation rates due to side effects are highest during initial titration and decrease significantly in the second year of treatment.
Can I stay on Wegovy indefinitely, or do long-term risks increase?
Current evidence supports extended Wegovy use beyond 2 years in appropriate patients, with the SELECT trial demonstrating safety up to 5 years. However, treatment duration should be individualised based on response, tolerability, and ongoing medical supervision by your UK prescriber.
Will wegovy long term side effects affect my fertility or pregnancy?
Wegovy should be discontinued at least 2 months before planned pregnancy due to limited human data on fetal outcomes. Women of childbearing potential should use reliable contraception during treatment, as weight loss itself may increase fertility in some patients with obesity-related reproductive dysfunction.
How do I know if my symptoms are normal wegovy long term side effects or something serious?
Mild, intermittent nausea and reduced appetite are expected effects, whilst severe persistent abdominal pain, repeated vomiting, vision changes, or mood disturbances warrant immediate medical assessment. Contact our clinical team or your GP if you're uncertain about any symptoms.
Does Wegovy cause permanent changes to metabolism or digestion?
Metabolic rate decreases proportionally to weight loss but is not permanently altered by semaglutide itself. Gastric emptying returns to normal within weeks of discontinuation, though maintaining weight loss requires ongoing lifestyle modifications regardless of medication history.
Are wegovy long term side effects different in older adults?
Older adults (over 65) generally experience similar side effect profiles, though dehydration risk from gastrointestinal symptoms may be higher. Renal function monitoring is particularly important in this population, as age-related kidney changes can affect medication clearance.
Can I reduce my Wegovy dose to minimise long-term side effects?
Dose reduction may be appropriate for patients experiencing persistent side effects, though this should only be done under prescriber guidance. Some patients maintain weight loss on lower maintenance doses (1.7mg rather than 2.4mg), balancing efficacy against tolerability.
What happens to wegovy long term side effects if I stop treatment suddenly?
Discontinuing Wegovy does not cause withdrawal symptoms, and side effects typically resolve within 4-5 weeks as semaglutide clears from your system. However, stopping without a weight maintenance plan often leads to weight regain, so discuss discontinuation strategies with your prescriber.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.